Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIO 300 with Chemoradiation in NSCLC
NCT02567799Phase 2Completed
- Sponsor
- Humanetics
- Start
- Nov 2015
- Primary completion
- Apr 2019
- Modality
- Nanoparticles, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of BIO 300 in radiation-induced pneumonitis (RP), pulmonary fibrosis (PF), sponsored by Humanetics. Started Nov 2015; status: completed.
02
Drugs
BIO 300
03
Conditions
radiation-induced pneumonitis (RP)pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT02567799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02567799.